120
Participants
Start Date
March 16, 2021
Primary Completion Date
June 14, 2023
Study Completion Date
August 13, 2023
Sugammadex
At the end of the surgical procedure at a depth of neuromuscular blockade after the reappearance of T2 on the train-of-four, Sugammadex will be dosed once at 2 mg/kg actual body weight through an intravenous line with brisk flow
Neostigmine
At the end of surgical procedure at a depth of neuromuscular blockade after the reappearance of T2 on the train-of-four, Neostigmine will be dosed once at 0.07 mg/kg actual body weight to a maximum of 5 mg through an intravenous line with brisk flow. Glycopyrrolate will be coadministered with Neostigmine at a dose of 0.2 mg of Glycopyrrolate per 1.0 mg of Neostigmine administered
Oregon Health & Science University, Portland
Merck Sharp & Dohme LLC
INDUSTRY
Oregon Health and Science University
OTHER